Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 31 results.
User Information
Export Records
  1. 1.   Resveratrol trimer enhances gene delivery to hematopoietic stem cells by reducing antiviral restriction at endosomes
  2. Ozog, Stosh; Timberlake, Nina D.; Hermann, Kip; Garijo, Olivia; Haworth, Kevin G.; Shi,Scarlett; Glinkerman, Christopher M.; Schefter, Lauren E.; D'Souza, Saritha; Simpson, Elizabeth; Sghia-Hughes, Gabriella; Carillo, Raymond R.; Boger, Dale L.; Kiem, Hans-Peter; Slukvin, Igor; Ryu, Byoung Y.; Sorrentino, Brian P.; Adair, Jennifer E.; Snyder, Scott A.; Compton,Alex; Torbett, Bruce E.
  3. BLOOD. 2019, OCT 17; 134: 1298-1311.
  1. 2.   Structural analyses of 4-phosphate adaptor protein 2 yield mechanistic insights into sphingolipid recognition by the glycolipid transfer protein family
  2. Ochoa-Lizarralde, Borja; Gao, Yong-Guang; Popov, Alexander N; Samygina, Valeria R; Zhai, Xiuhong; Mishra, Shrawan K; Boldyrev, Ivan A; Molotkovsky, Julian G; Simanshu, Dhirendra; Patel, Dinshaw J; Brown, Rhoderick E; Malinina, Lucy
  3. Journal of Biological Chemistry. 2018, Sep 11; pii: jbc.RA117.000733.
  1. 3.   The interdomain linker region of HIV-1 capsid protein is a critical determinant of proper core assembly and stability
  2. Jiang, J. Y.; Ablan, S. D.; Derebail, S.; Hercik, K.; Soheilian, F.; Thomas, J. A.; Tang, S. X.; Hewlett, I.; Nagashima, K.; Gorelick, R. J.; Freed, E. O.; Levin, J. G.
  3. Virology. 2011, Dec; 421(2): 253-265.
  1. 4.   The Role of ITCH Protein in Human T-cell Leukemia Virus Type 1 Release
  2. Dorjbal, B.; Derse, D.; Lloyd, P.; Soheilian, F.; Nagashima, K.; Heidecker, G.
  3. Journal of Biological Chemistry. 2011, Sep; 286(36): 31092-31104.
  1. 5.   Immunization with Single-Cycle SIV Significantly Reduces Viral Loads After an Intravenous Challenge with SIV(mac)239
  2. Jia, B.; Ng, S. K.; DeGottardi, M. Q.; Piatak, M.; Yuste, E.; Carville, A.; Mansfield, K. G.; Li, W. J.; Richardson, B. A.; Lifson, J. D.; Evans, D. T.
  3. Plos Pathogens. 2009 5(1): 1-19.
  1. 6.   Retroviruses Human Immunodeficiency Virus and Murine Leukemia Virus Are Enriched in Phosphoinositides
  2. Chan, R.; Uchil, P. D.; Jin, J.; Shui, G. H.; Ott, D. E.; Mothes, W.; Wenk, M. R.
  3. Journal of Virology. 2008 82(22): 11228-11238.
  1. 7.   CD45 immunoaffinity depletion of vesicles from Jurkat T cells demonstrates that exosomes contain CD45: no evidence for a distinct exosome/HIV-I budding pathway
  2. Coren, L. V.; Shatzer, T.; Ott, D. E.
  3. Retrovirology. 2008 5: 1-5.
  1. 8.   3 molecular characterization of feline immunodeficiency virus budding
  2. Luttge, B. G.; Shehu-Xhilaga, M.; Demirov, D. G.; Adamson, C. S.; Soheilian, F.; Nagashima, K.; Stephen, A. G.; Fisher, R. J.; Freed, E. O.
  3. Journal of Virology. 2008 82(5): 2106-2119.
  1. 9.   Efficiency of human immunodeficiency virus type 1 postentry infection processes: Evidence against disproportionate numbers of defective virions
  2. Thomas, J. A.; Ott, D. E.; Gorelick, R. J.
  3. Journal of Virology. 2007, Apr; 81(8): 4367-4370.
  1. 10.   An Alix fragment potently inhibits HIV-1 budding - Characterization of binding to retroviral YPXL late domains
  2. Munshi, U. M.; Kim, J.; Nagashima, K.; Hurley, J. H.; Freed, E. O.
  3. Journal of Biological Chemistry. 2007, Feb; 282(6): 3847-3855.
  1. 11.   Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages
  2. Chertova, E.; Chertov, O.; Coren, L. V.; Roser, J. D.; Trubey, C. M.; Bess, J. W.; Sowder, R. C.; Barsov, E.; Hood, B. L.; Fisher, R. J.; Nagashima, K.; Conrads, T. P.; Veenstra, T. D.; Lifson, J. D.; Ott, D. E.
  3. Journal of Virology. 2006, Sep; 80(18): 9039-9052.
  1. 12.   Discovery of small-molecule human immunodeficiency virus type 1 entry inhibitors that target the gp120-binding domain of CD4
  2. Yang, Q. E.; Stephen, A. G.; Adelsberger, J. W.; Roberts, P. E.; Zhu, W. M.; Currens, M. J.; Feng, Y. X.; Crise, B. J.; Gorelick, R. J.; Rein, A. R.; Fisher, R. J.; Shoemaker, R. H.; Sei, S.
  3. Journal of Virology. 2005, MAY; 79(10): 6122-6133.
  1. 13.   Association of Ebola virus matrix protein VP40 with microtubules
  2. Ruthel, G.; Demmin, G. L.; Kallstrom, G.; Javid, M. P.; Badie, S. S.; Will, A. B.; Nelle, T.; Schokman, R.; Nguyen, T. L.; Carra, J. H.; Bavari, S.; Aman, M. J.
  3. Journal of Virology. 2005, APR; 79(8): 4709-4719.
  1. 14.   Elimination of retroviral infectivity by N-ethylmaleimide with preservation of functional envelope glycoproteins
  2. Morcock, D. R.; Thomas, J. A.; Gagliardi, T. D.; Gorelick, R. J.; Roser, J. D.; Chertova, E. N.; Bess, J. W.; Ott, D. E.; Sattentau, Q. J.; Frank, I.; Pope, M.; Lifson, J. D.; Henderson, L. E.; Crise, B. J.
  3. Journal of Virology. 2005, FEB; 79(3): 1533-1542.
  1. 15.   Mechanisms of nonrandom human immunodeficiency virus type 1 infection and double infection: Preference in virus entry is important but is not the sole factor
  2. Chen, J. B.; Dang, Q.; Unutmaz, D.; Pathak, V. K.; Maldarelli, F.; Powell, D.; Hu, W. S.
  3. Journal of Virology. 2005 79(7): 4140-4149.
  1. 16.   Dynamic fluorescent imaging of human immunodeficiency virus type 1 Gag in live cells by biarsenical labeling
  2. Rudner, L.; Nydegger, S.; Coren, L. V.; Nagashima, K.; Thali, M.; Ott, D. E.
  3. Journal of Virology. 2005 79(7): 4055-4065.
  1. 17.   Retrovirus budding
  2. Demirov, D. G.; Freed, E. O.
  3. Virus Research. 2004, DEC; 106(2): 87-102.
  1. 18.   Virus entry: Molecular mechanisms and biomedical applications
  2. Dimitrov, D. S.
  3. Nature Reviews Microbiology. 2004 2(2): 109-122.
  1. 19.   HIV-1 and the host cell: an intimate association
  2. Freed, E. O.
  3. Trends in Microbiology. 2004 12(4): 170-177.
  1. 20.   Late assembly motifs of human T-cell leukemia virus type 1 and their relative roles in particle release
  2. Heidecker, G.; Lloyd, P. A.; Fox, K.; Nagashima, K.; Derse, D.
  3. Journal of Virology. 2004 78(12): 6636-6648.
  1. 21.   Cell-type-dependent targeting of human immunodeficiency virus type 1 assembly to the plasma membrane and the multivesicular body
  2. Ono, A.; Freed, E. O.
  3. Journal of Virology. 2004 78(3): 1552-1563.
  1. 22.   Late domain-dependent inhibition of equine infectious anemia virus budding
  2. Miranda, S. X.; Ablan, S.; Demirov, D. G.; Chen, C. P.; Montelaro, R. C.; Freed, E. O.
  3. Journal of Virology. 2004 78(2): 724-732.
  1. 23.   Retroviruses have differing requirements for proteasome function in the budding process
  2. Ott, D. E.; Coren, L. V.; Sowder, R. C.; Adams, J.; Schubert, U.
  3. Journal of Virology. 2003 77(6): 3384-3393.
  1. 24.   In vivo oligomerization and raft localization of Ebola virus protein VP40 during vesicular budding
  2. Panchal, R. G.; Ruthel, G.; Kenny, T. A.; Kallstrom, G. H.; Lane, D.; Badie, S. S.; Li, L. M.; Bavari, S.; Aman, M. J.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2003 100(26): 15936-15941.
  1. 25.   Modulation of entry of enveloped viruses by cholesterol and sphingolipids (Review)
  2. Rawat, S. S.; Viard, M.; Gallo, S. A.; Rein, A.; Blumenthal, R.; Puri, A.
  3. Molecular Membrane Biology. 2003 20(3): 243-254.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel